Recent News

• 08.26.2025 - Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
• 08.21.2025 - Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book
• 08.14.2025 - Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.06.2025 - Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038
• 07.09.2025 - Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036
• 07.09.2025 - Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036

Recent Filings

• 08.14.2025 - 8-K Current report
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.14.2025 - EX-99.1 EX-99.1
• 08.06.2025 - 8-K Current report
• 07.09.2025 - 8-K Current report
• 07.09.2025 - EX-99.1 EX-99.1
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities